Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
The conservative think tank has filed thousands of public-information requests, clogging the pipeline at federal agencies in ...
FTC began the process to unionize back in 2023, raising concerns about their access to telework, potential politicization of the civil service and other issues.
Federal regulators have filed an administrative complaint against the St. Louis-based pharmacy benefit manager. Patients and ...
The Federal Trade Commission says a $48 million settlement should put an end to what it calls "predatory" tactics by the ...
Ohio Attorney General Dave Yost and 11 other Republican attorneys general on Monday filed a brief in federal court in ...
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
The FTC is warning Ohioans that consumer scams are on the rise, and unfortunately, scammers are growing more sophisticated in laying their traps.
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
As the youngest ever Federal Trade Commission chair, Lina Khan has taken on scores of companies and preached the perils of business monopolies. Her pursuit of big business represents a policy ...
On Oct. 7, the 5th Circuit Court of Appeals will hear arguments in a case that could significantly reshape how auto dealerships operate. The National ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback